These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23183387)

  • 1. Delayed-release prednisone (Rayos).
    Med Lett Drugs Ther; 2012 Nov; 54(1404):94. PubMed ID: 23183387
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the Availability of Delayed-Release Prednisone an Important Clinical Advance?
    Conn DL
    Arthritis Care Res (Hoboken); 2016 Mar; 68(3):412-3. PubMed ID: 26414513
    [No Abstract]   [Full Text] [Related]  

  • 3. Protocol design.
    Wilensky AJ
    Epilepsy Res Suppl; 1993; 10():107-13. PubMed ID: 8251086
    [No Abstract]   [Full Text] [Related]  

  • 4. Full-day ADHD symptom control that "lasts from home to homework".
    Pediatr Nurs; 2000; 26(6):634-5. PubMed ID: 12026370
    [No Abstract]   [Full Text] [Related]  

  • 5. Sending pharma better signals.
    Avorn J
    Science; 2005 Jul; 309(5735):669. PubMed ID: 16051753
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral controlled release preparations.
    García CR; Siqueiros A; Benet LZ
    Pharm Acta Helv; 1978; 53(3-4):99-109. PubMed ID: 360228
    [No Abstract]   [Full Text] [Related]  

  • 7. A morphine/naltrexone combination (Embeda) for pain.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):22-3. PubMed ID: 20336033
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overhauling clinical trials.
    Scott CT; Baker M
    Nat Biotechnol; 2007 Mar; 25(3):287-92. PubMed ID: 17344876
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypothesis: a single clinical trial plus causal evidence of effectiveness is sufficient for drug approval.
    Peck CC; Rubin DB; Sheiner LB
    Clin Pharmacol Ther; 2003 Jun; 73(6):481-90. PubMed ID: 12811358
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenomics. Going from genome to pill.
    Service RF
    Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283
    [No Abstract]   [Full Text] [Related]  

  • 12. Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2012 Jun; 73(6):856-64. PubMed ID: 22687813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated approval of oncology drugs: can we do better?
    Ellenberg SS
    J Natl Cancer Inst; 2011 Apr; 103(8):616-7. PubMed ID: 21422401
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecule of the Month. Varenicline tartrate.
    Drug News Perspect; 2006 Apr; 19(3):162. PubMed ID: 16804568
    [No Abstract]   [Full Text] [Related]  

  • 15. Accelerated approval of oncology products: the food and drug administration experience.
    Johnson JR; Ning YM; Farrell A; Justice R; Keegan P; Pazdur R
    J Natl Cancer Inst; 2011 Apr; 103(8):636-44. PubMed ID: 21422403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pit (of sleeplessness) and the pendulum (of regulation).
    Bliwise DL
    Sleep Med; 2010 Jan; 11(1):7-8. PubMed ID: 19945339
    [No Abstract]   [Full Text] [Related]  

  • 17. Leuprolide acetate for the treatment of endometriosis.
    Miller JD
    Prog Clin Biol Res; 1990; 323():337-41. PubMed ID: 2106145
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug pipeline: Q311.
    Peng W
    Nat Biotechnol; 2011 Oct; 29(10):859. PubMed ID: 21997619
    [No Abstract]   [Full Text] [Related]  

  • 19. To market, to market. The nuts and bolts of prescription drug approval.
    Peterson AM
    Adv Nurse Pract; 2001 Apr; 9(4):87-90. PubMed ID: 12420443
    [No Abstract]   [Full Text] [Related]  

  • 20. Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program.
    Stark Y
    Ann Neurol; 1994 Jul; 36(1):114-5. PubMed ID: 8024251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.